title: Reversal of protein-losing enteropathy with heparin therapy in an adult patient with congenital heart disease.
authors.forename: Takao
authors.initials: T
authors.lastname: Tsuzuki
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Okada
authors.forename: Ryuta
authors.initials: R
authors.lastname: Takenaka
authors.forename: Yoshiro
authors.initials: Y
authors.lastname: Kawahara
authors.forename: Jun
authors.initials: J
authors.lastname: Kato
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Okazaki
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Kawamoto
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Shiratori
mesh_terms: D000328:Adult; D000418:Albumins / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D018729:Fontan Procedure; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D007413:Intestinal Mucosa / Q000187:drug effects / Q000473:pathology; D008297:Male; D011504:Protein-Losing Enteropathies / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D011666:Pulmonary Valve Stenosis / Q000150:complications / Q000151:congenital / Q000601:surgery*; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D000418:Albumins; D006493:Heparin